As per the report, the next-generation sequencing market size was US$ 6.37 billion in 2021. It is projected to grow US$ 24.48 billion by 2030 at a CAGR of 16.1% in the forecast period.
Next-generation sequencing (NGS) is a massively parallel sequencing method that provides scalability, ultra-high throughput, and high speed for determining the order of nucleotides throughout the genome. Because it involves the preparation of the material for the subsequent sequencing reaction, DNA pre-sequencing is one of the most important processes in the overall sequencing protocol. Globally, NGS is becoming more incorporated into clinical laboratory analysis, testing, and disease diagnostics in the healthcare sector. In pharmacogenomic, next-generation sequencing (NGS) is commonly used to speed up the drug discovery process.
Download the FREE Sample Report (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1454
Market Overview
A recent study by Precedence Research on the next-generation sequencing market offers a forecast for 2021 and 2030. The study analyzes crucial trends that are currently determining the growth of the next-generation sequencing market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of next-generation sequencing. The study also provides the dynamics that are responsible for influencing the future status of this market over the forecast period.
A detailed assessment of the next-generation sequencing market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the next-generation sequencing market along with their product portfolio enhances the reliability of this comprehensive research study.
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
Key Points
- Primary Research
- Secondary Research
- Market Size Estimation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends and Assessment
- Market Factor Analysis
- Porter’s Five Forces Analysis
- Bargaining Power Of Suppliers
- Bargaining Power Of Buyers
- Threat Of New Entrants
- Threat Of Substitutes
- Intensity Of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
Research Methodology
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, the structure of the market participants and industry's competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Industry participants involved in this research study include:
- CEOs, VPs, market intelligence managers
- Procuring and national sales managers technical personnel, distributors and resellers
- Research analysts and key opinion leaders from various domains
Competition Landscape
In the final section of the report on the global next-generation sequencing market, a 'dashboard view' of the companies has been provided to compare the current market scenario and the contribution of companies to the global next-generation sequencing market. Moreover, the report is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to segments of the global market. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the next-generation sequencing marketplace.
Some of the prominent players in the global next-generation sequencing market include:
- BGI Group
- F. Hoffmann-La Roche AG
- Pacific Biosciences of California Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Precigen Inc.
- Illumina Inc.
- Qiagen N.V.
- PerkinElmer Inc.
- PierianDx Inc.
Market Segmentation
Segments of the global next-generation sequencing market have been analyzed in terms of their market share to understand an individual segment’s relative contribution to market growth. This detailed level of information is important for identifying key trends in the global next-generation sequencing market.
Market Segments as below:
By Product
- Consumables Platforms
- Services and Nerve Blockers
By Application
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Agriculture and Animal Research
- Others
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Others
By End User
- Academic and Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Clinical Research
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Next Generation Sequencing Market
5.1. COVID-19 Landscape: Next Generation Sequencing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Next Generation Sequencing Market, By Product
8.1. Next Generation Sequencing Market, by Product Type, 2021-2030
8.1.1. Consumables Platforms
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Services and Nerve Blockers
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Next Generation Sequencing Market, By Application
9.1. Next Generation Sequencing Market, by Application, 2021-2030
9.1.1. Diagnostics
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Biomarkers and Cancer
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Reproductive Health
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Personalized Medicine
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Agriculture and Animal Research
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Next Generation Sequencing Market, By Technology Type
10.1. Next Generation Sequencing Market, by Technology Type, 2021-2030
10.1.1. Sequencing by Synthesis
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Ion Semiconductor Sequencing
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Sequencing by Ligation
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Pyrosequencing
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Single Molecule Real Time Sequencing
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Next Generation Sequencing Market, By End User Type
11.1. Next Generation Sequencing Market, by End User Type, 2021-2030
11.1.1. Academic and Research Centers
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Pharmaceutical and Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Hospitals and Clinics
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Clinical Research
11.1.4.1. Market Revenue and Forecast (2019-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Next Generation Sequencing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
Chapter 13. Company Profiles
13.1. BGI Group
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann-La Roche AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Pacific Biosciences of California Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Agilent Technologies Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Precigen Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Illumina Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Qiagen N.V.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. PerkinElmer Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. PierianDx Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Why Buy this Report?
The purpose of Precedence Research's next-generation sequencing market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1454
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments